6
Views
4
CrossRef citations to date
0
Altmetric
Research Article

In Vitro Effects of two Gold Compounds, and D-Penicillamine on the Producn of Interferon Gamma

, &
Pages 39-60 | Published online: 28 Sep 2008
 

Abstract

There are contradictory reports on Interferon Gamma (IFNγ) production by peripheral blood mononuclear cells (PBMC) in rheumatoid arthritis (RA). Since many patients previously studied were on Gold Sodium Thiomalate (GST), Auranofin (Auf), or D-Penicillamine (D-Pen) we have investigated the effects of these drugs on IFNγ production using PBMC from normal controls (NO, and RA patients off GST, Auf, and D-Pen. Auf in low concentrations enhanced IFNγ production by PBMC from NC but not RA; GST, and D-Pen had no effect. In other experiments PBMC were stimulated with concanavalin A (CONA A), or phytohemagglutinin (PHA). Auf, and GST inhibited IFNγ production by CON A - stimulated NC and RA cells; D-Pen had no effect. Auf in low concentrations enhanced IFNγ production by PHA - stimulated NC cells, but this effect was not seen with RA cells; GST inhibited both RA and NC cell production of IFNγ, and D-Pen had no effect. Auf has a biphasic effect on IFNy production by NC cells with low concentrations being stimulatory or co-stimulatory, possibly by acting on T helper cells. Higher concentations of Auf and GST, equivalent to those achieved in vivo in the course of therapy, inhibit IFNγ production. These results suggest that gold therapy may affect IFNγ production in RA, and could explain discrepancies noted in previous studies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.